SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-17-016415
Filing Date
2017-09-28
Accepted
2017-09-27 21:45:41
Documents
27
Period of Report
2017-09-28
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K plxp20170926_8k.htm 8-K 21496
2 EXHIBIT 99.1 ex_96000.htm EX-99.1 13405
3 a25.jpg GRAPHIC 30189
4 a24.jpg GRAPHIC 73664
5 a23.jpg GRAPHIC 92919
6 a22.jpg GRAPHIC 91444
7 a21.jpg GRAPHIC 84041
8 a20.jpg GRAPHIC 85755
9 a19.jpg GRAPHIC 82802
10 a18.jpg GRAPHIC 104677
11 a17.jpg GRAPHIC 98878
12 a16.jpg GRAPHIC 97884
13 a15.jpg GRAPHIC 91547
14 a14.jpg GRAPHIC 88709
15 a13.jpg GRAPHIC 97468
16 a12.jpg GRAPHIC 61283
17 a11.jpg GRAPHIC 79210
18 a10.jpg GRAPHIC 93719
19 a09.jpg GRAPHIC 88357
20 a08.jpg GRAPHIC 65224
21 a07.jpg GRAPHIC 37216
22 a06.jpg GRAPHIC 108827
23 a05.jpg GRAPHIC 108436
24 a04.jpg GRAPHIC 81158
25 a03.jpg GRAPHIC 62859
26 a02.jpg GRAPHIC 158949
27 a01.jpg GRAPHIC 59021
  Complete submission text file 0001437749-17-016415.txt   2959616
Mailing Address 8285 EL RIO STREET SUITE 130 HOUSTON TX 77054
Business Address 8285 EL RIO STREET SUITE 130 HOUSTON TX 77054 (713) 842-1249
PLx Pharma Inc. (Filer) CIK: 0001497504 (see all company filings)

IRS No.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36351 | Film No.: 171105443
SIC: 2834 Pharmaceutical Preparations